Table 3.

Enriched biological terms and pathways of SNHG17 in prostate cancer.

Ontology	ID	Description	Gene ratio	BgRatio	p value	p.adjust	q value
BP	GO:0051101	Regulation of DNA binding	13/560	124/18670	9.07e − 05	0.009	0.008
BP	GO:0090068	Positive regulation of cell cycle process	22/560	298/18670	1.02e − 04	0.010	0.009
BP	GO:1904668	Positive regulation of ubiquitin protein ligase activity	4/560	12/18670	3.27e − 04	0.019	0.018
CC	GO:0000779	Condensed chromosome, centromeric region	18/612	118/19717	2.43e − 08	1.13e − 05	1.07e − 05
CC	GO:0000777	Condensed chromosome kinetochore	16/612	105/19717	1.48e − 07	3.43e − 05	3.26e − 05
MF	GO:0001228	DNA-binding transcription activator activity, RNA polymerase II-specific	30/561	439/17697	7.13e − 05	0.008	0.007
MF	GO:0048018	Receptor ligand activity	30/561	482/17697	3.62e − 04	0.033	0.031
KEGG	hsa03010	Ribosome	14/229	158/8076	1.50e − 04	0.025	0.024
KEGG	hsa04110	Cell cycle	12/229	124/8076	1.95e − 04	0.025	0.024